INOVIO PHARMACEUTICALS, INC. Operating Lease Right-of-Use Assets
INOVIO PHARMACEUTICALS, INC. (INO) had Operating Lease Right-of-Use Assets of $5.67 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-12
- 2026-06-30: Operating Lease, Right-of-Use Asset $5.67M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $6.11M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $6.54M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $6.96M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $5.67M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $6.11M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $6.54M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $6.96M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $7.36M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $7.74M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $8.11M 10-K · filed 2026-03-12 |
| 2024-09-30 | $8.47M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $8.82M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $9.16M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $9.49M 10-K · filed 2025-03-18 |
| 2023-09-30 | $9.10M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $9.49M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $9.87M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $10.23M 10-K · filed 2024-03-06 |
| 2022-09-30 | $10.58M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $10.91M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $11.25M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $11.57M 10-K · filed 2023-03-01 |
| 2021-09-30 | $11.88M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $12.17M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $12.46M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $12.74M 10-K · filed 2022-03-01 |
| 2020-09-30 | $13.01M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $13.27M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $13.51M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $13.78M 10-K · filed 2021-03-01 |
| 2019-09-30 | $14.00M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $14.22M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $14.43M 10-Q · filed 2019-05-09 |
| 2019-01-01 | $14.63M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |